The treatment showed stability or improvement in the Diabetic Retinopathy Severity Scale (DRSS) and generally the drug was well tolerated.

Fourteen-day continuous glucose monitoring (CGM) traces added to Diabetes Control and Complications Trial (DCCT) data can predict microvascular diabetes complications similarly to glycated hemoglobin.

Highlighting the event is the immersive simulation, “Seeing Beyond the Ordinary and Repairing Damages,” led by world-renowned ...

The implementation of AIDRSS offers transformative implications for DR screening in India, particularly in rural and ...

The collaboration will focus on preventive solutions, workshops, and public awareness. King Faisal Specialist Hospital and ...

Mysuru: Mysuru district health authorities, in association with the District Blind Control Society, launched a mobile eye ...

Arogya Aarohan app & other AI-driven tools are being tested for early detection of diseases as part of Rs 300-cr initiative ...

Diabetic retinopathy is a common complication in people with type 1 and type 2 diabetes, progressing from mild, moderate, and ...

THE NHS is urging people with diabetes to book an eye appointment. North Cumbria Integrated Care (NCIC) is offering eye screening appointments to people with diabetes across the county. In a post on ...

Over 537 million people globally suffer from diabetes, with 227 million in Asia Pacific. More than half may develop diabetic retinopathy (DR) within 10 years, potentially leading to blindness.

The Diabetic Retinopathy Clinical Research (DRCR) Network, which includes over 199 participating sites, is currently evaluating many of these treatments in RCTs.